Rheumatology
Partner With Us
Advertisement
Conexiant chevron_right Rheumatology chevron_right GLP 1 Drugs Lower Death and Heart Risks in Patients With Inflammatory Diseases and Diabetes
From the Journals

GLP-1 Drugs Lower Death and Heart Risks in Patients With Inflammatory Diseases and Diabetes

Study shows certain diabetes medications dramatically reduce mortality and heart risks in patients with inflammatory diseases like rheumatoid arthritis.

Conexiant

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.